Supriya Pharmaceuticals Limited

Founded in 1985 and headquartered in Rajasthan, India.

1985 | Alwar, Rajasthan (India) | Active
Last Updated:

Supriya Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 4.64 Cr
  • Company Age 39 Year, 7 Months
  • Last Filing with ROC 31 Mar 2019
  • Open Charges ₹ 3.00 Cr
  • Satisfied Charges ₹ 4.94 Cr
  • Revenue Growth %
  • Ebitda
  • Net Worth
  • Total Assets 6.92%

About Supriya Pharmaceuticals

Supriya Pharmaceuticals Limited (SPL) is a Public Limited Indian Non-Government Company incorporated in India on 24 July 1985 and has a history of 39 years and seven months. Its registered office is in Alwar, Rajasthan, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 4.64 Cr.

The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹4.94 Cr, as per Ministry of Corporate Affairs (MCA) records.

Ramesh Dugar, Manish Gupta, and Yogesh Kumar serve as directors at the Company.

Company Details

  • Location

    Alwar, Rajasthan, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U01100RJ1985PLC003363

  • Company No.

    003363

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    24 Jul 1985

  • Date of AGM

    19 Aug 2019

  • Date of Balance Sheet

    31 Mar 2019

  • Listing Status

    Unlisted

  • ROC Code

    Roc Jaipur

Industry

Pharma

Who are the key members and board of directors at Supriya Pharmaceuticals?

Board Members (3)

NameDesignationAppointment DateStatus
Ramesh Dugar Country flag representing In Nominee Director 08-Feb-2012Current
Manish Gupta Country flag representing In Nominee Director 06-Feb-2024Current
Yogesh Kumar Country flag representing In Nominee Director 16-May-2017Current

Financial Performance of Supriya Pharmaceuticals.

Supriya Pharmaceuticals Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Supriya Pharmaceuticals revenue growth over time
Supriya Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
6.92%
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Supriya Pharmaceuticals?

In 2019, Supriya Pharmaceuticals had a promoter holding of 35.36% and a public holding of 64.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹3.00 Cr

Satisfied Charges

₹4.94 Cr

Charges Breakdown by Lending Institutions

  • United Bank Of India : 3.00 Cr

Latest Charge Details

DateLenderAmountStatus
22 Aug 2005United Bank Of India₹3.00 CrOpen
21 Jan 1998Canara Bank₹0.30 MSatisfied
20 Aug 1992Canara Bank₹3.00 CrSatisfied
31 Jan 1992Canara Bank₹3.00 MSatisfied
16 Aug 1991Canara Bank₹5.50 MSatisfied

How Many Employees Work at Supriya Pharmaceuticals?

Unlock and access historical data on people associated with Supriya Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Supriya Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Supriya Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supriya Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Supriya Pharmaceuticals

Recent activity within the organization

  • Director Appointment

    Manish Gupta was appointed as a Nominee Director was appointed as a Nominee Director on 06 Feb 2024 & has been associated with this company since 1 year 27 days .

  • Annual General Meeting

    Supriya Pharmaceuticals Limited last Annual general meeting of members was held on 19 Aug 2019 as per latest MCA records.

  • Balance Sheet

    Supriya Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Jaipur.

  • Director Appointment

    Yogesh Kumar was appointed as a Nominee Director was appointed as a Nominee Director on 16 May 2017 & has been associated with this company since 7 years 9 months .

  • Director Appointment

    Ramesh Dugar was appointed as a Nominee Director was appointed as a Nominee Director on 08 Feb 2012 & has been associated with this company since 13 years 25 days .

  • Charges

    A charge registered on 21 Jan 1998 via Charge ID 90066760 with Canara Bank was fully satisfied on 09 Jul 2009.

Frequently asked questions

  • What is the Incorporation or founding date of Supriya Pharmaceuticals Limited?

    Supriya Pharmaceuticals Limited was incorporated on 24 Jul 1985.

  • What is authorized share capital and paid-up capital of Supriya Pharmaceuticals Limited?

    The authorized share capital of Supriya Pharmaceuticals Limited is ₹ 10.00 Cr and paid-up capital is ₹ 4.64 Cr.

  • Who are the current board members & directors of Supriya Pharmaceuticals Limited?

    Currently 3 directors are associated with Supriya Pharmaceuticals Limited.

    • Ramesh Dugar
    • Manish Gupta
    • Yogesh Kumar

  • What is the registered address of Supriya Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Supriya Pharmaceuticals Limited is Khesra No 238/13 Ambit Education Llp Gram Thada, Tehsil Tizara India, Bhiwadi, Rajasthan, 301019.

  • What is the corporate identification number (CIN) and company number of Supriya Pharmaceuticals Limited?

    The corporate identification number (CIN) of Supriya Pharmaceuticals Limited is U01100RJ1985PLC003363 and the company number is 003363 as per Ministry of Corporate Affairs (MCA).

  • What are the total open charges for Supriya Pharmaceuticals Limited?

    As per the financial statements for fiscal Year 2019, The total open charges for Supriya Pharmaceuticals Limited amount to ₹ 3.00 Cr.

  • When was the last Balance Sheet of Supriya Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Supriya Pharmaceuticals Limited was filed with the ROC on 31 Mar 2019.

People also Viewed

Similar Companies Based on Drug Formulation & Development